Health Care & Life Sciences » Biotechnology | Voyager Therapeutics Inc.

Voyager Therapeutics Inc. | Ownership

Companies that own Voyager Therapeutics Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Bellevue Asset Management AG
2,549,563
7.86%
556,922
0.8%
06/30/2018
BlackRock Fund Advisors
1,725,847
5.32%
373,902
0%
06/30/2018
Fidelity Management & Research Co.
1,686,862
5.2%
-645,359
0%
07/31/2018
SSgA Funds Management, Inc.
1,229,912
3.79%
430,966
0%
06/30/2018
Casdin Capital LLC
1,135,000
3.5%
0
3.41%
06/30/2018
The Vanguard Group, Inc.
1,040,105
3.21%
111,274
0%
06/30/2018
Highline Capital Management LLC
840,670
2.59%
840,670
0.65%
06/30/2018
Farallon Capital Management LLC
768,157
2.37%
-121,843
0.11%
06/30/2018
Great Point Partners LLC
730,010
2.25%
730,010
2.18%
06/30/2018
Eventide Asset Management LLC
703,425
2.17%
0
0.57%
06/30/2018

About Voyager Therapeutics

View Profile
Address
75 Sidney Street
Cambridge Massachusetts 02139
United States
Employees -
Website http://www.voyagertherapeutics.com
Updated 07/08/2019
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.